Skip to content

A multicenter study evaluating the diagnostic value for vascular abnormalities of High Definition Bronchoscopy when combined with i-scan Imaging Technology compared to High Defintion Bronchoscopy alone

A multicenter study evaluating the diagnostic value for vascular abnormalities of High Definition Bronchoscopy when combined with i-scan Imaging Technology compared to High Defintion Bronchoscopy alone - i-scan multicenter study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON40848
Enrollment
30
Registered
2014-10-02
Start date
2014-10-17
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lungcancer

Interventions

None listed

Sponsors

Universitair Medisch Centrum Sint Radboud
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -Patients with indication for diagnostic bronchoscopy for suspected or proven lung cancer. -ASA physical status 1-3. -Age 18 years or older.

Exclusion criteria

Exclusion criteria: -Bleeding disorders. -Indication for use of anticoagulant therapy (acenocoumarol, warfarin, therapeutic dose of low molecular weight heparines or clopidrogel). -Known allergy for lidocaine. -Known pulmonary hypertension. -Recent and/or uncontrolled cardiac disease. -Compromised upper airway (eg concomitant head and neck cancer or central airway stenosis for any reason). -ASA classification greater than or equal to 4. -Pregnancy.

Design outcomes

Primary

MeasureTime frame
Determing the positive predictive value and diagnostic yield of HD+ i-scan bronchoscopy for vascular pattern detection compared to histology.

Secondary

MeasureTime frame
• To investigate the correlation of vascular abnormalities with histology • To investigate the impact of i-scan technology on the clinical approach or follow-up plan • To investigate the interobserver variability • Investigate diagnostic performance and determing the positive predictive value of HD+ i-scan bronchoscopy in comparison to normal HD-WL on demarcation of tumour margins

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)